Tian Xie

机构：Union Hospital, Hangzhou Normal University, The University of Queensland, Southwest Forestry University, Hangzhou Hospital of Traditional Chinese Medicine, National Power (United Kingdom), Huazhong University of Science and Technology, Northeastern University · ORCID：0009-0005-7977-5435

发表论文 34 篇 · 总被引 1425 次 · h-index 12

代表论文

• Nanosensitizer-mediated augmentation of sonodynamic therapy efficacy and antitumor immunity (2023 · Nature Communications · 被引 223)
• In situ Engineering of Tumor‐Associated Macrophages via a Nanodrug‐Delivering‐Drug (β‐Elemene@Stanene) Strategy for Enhanced Cancer Chemo‐Immunotherapy (2023 · Angewandte Chemie International Edition · 被引 85)
• Current Progress in Cancer Treatment Using Nanomaterials (2022 · Frontiers in Oncology · 被引 69)
• RORγt expression in mature T H 17 cells safeguards their lineage specification by inhibiting conversion to T H 2 cells (2022 · Science Advances · 被引 47)
• Screening and modification of (+)-germacrene A synthase for the production of the anti-tumor drug (−)-β-elemene in engineered Saccharomyces cerevisiae (2024 · International Journal of Biological Macromolecules · 被引 39)
• Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification (2022 · European Journal of Medicinal Chemistry · 被引 21)